Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Latinos have become increasingly concerned about how weight gain affects their health. Beyond abuelas and tias pushing them to eat more tamales at family gatherings, or being criticized about the size ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...

Which players did 13 of the best 2025 NBA Draft prospects compare themselves to? 106 players have filed as early entry candidates for the 2025 NBA Draft which will be held June 25-26. The Dallas ...

Over the past few years, demand for blockbuster medications like Ozempic, Wegovy and Zepbound skyrocketed. These drugs are typically prescribed to address a range of health issues, including ...

The primary includes 20 candidates, from which at least six typically are selected, and the veterans ballot has 12 candidates, from which two typically are inducted. The class will be announced in ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. ATLANTA (AP) — A day after Georgia Republican ...